 "US FDA lifts import alert on Divi's Lab Vizag unit in record seven months")
US Food and Drug Administration has lifted the import alert on Divi's Laboratories Vizag plant in record seven months. This is seen as unprecedented for Indian drug makers.
The import alert issued to Aurobindo Pharma's unit VI in Hyderabad was removed in 2013 two years after the issue while import bans on plants of Ipca Labs, Wockhardt and Sun Pharmaceutical Industries still remain in place.
Divi's Lab stock surged 16 per cent to Rs 1074 in intraday trade on the BSE after this positive development.
The FDA had issued an import alert under clauses 99-32 and 66-40 to the unit following an inspection last December. The alert under clause 99-32 was withdrawn in July.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%